$TALK
Talkspace, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024123526 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $47.40M
YoY Change 22.65%
Cost Of Revenue $25.78M
YoY Change 30.21%
Gross Profit $21.62M
YoY Change 14.71%
Gross Profit Margin 45.61%
Selling, General & Admin $17.49M
YoY Change -5.15%
% of Gross Profit 80.91%
Research & Development $2.352M
YoY Change -43.73%
% of Gross Profit 10.88%
Depreciation & Amortization $231.0K
YoY Change -23.0%
% of Gross Profit 1.07%
Operating Expenses $21.52M
YoY Change -10.43%
Operating Profit $99.00K
YoY Change -98.09%
Interest Expense $1.701M
YoY Change 118.08%
% of Operating Profit 1718.18%
Other Income/Expense, Net
YoY Change
Pretax Income $1.800M
YoY Change -59.09%
Income Tax -$74.00K
% Of Pretax Income -4.11%
Net Earnings $1.874M
YoY Change -142.46%
Net Earnings / Revenue 3.95%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 168.9M 168.2M
Diluted Shares Outstanding 173.8M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.0M
YoY Change -5.03%
Cash & Equivalents $119.0M
Short-Term Investments
Other Short-Term Assets $2.922M
YoY Change -33.79%
Inventory
Prepaid Expenses
Receivables $9.602M
Other Receivables $0.00
Total Short-Term Assets $131.5M
YoY Change -4.5%
LONG-TERM ASSETS
Property, Plant & Equipment $4.329M
YoY Change 1491.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.713M
YoY Change 1630.15%
Total Long-Term Assets $6.713M
YoY Change 155.15%
TOTAL ASSETS
Total Short-Term Assets $131.5M
Total Long-Term Assets $6.713M
Total Assets $138.2M
YoY Change -1.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.299M
YoY Change 27.44%
Accrued Expenses $6.282M
YoY Change -17.34%
Deferred Revenue $3.507M
YoY Change -3.18%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.05M
YoY Change -8.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $542.0K
YoY Change 185.26%
Total Long-Term Liabilities $542.0K
YoY Change 185.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.05M
Total Long-Term Liabilities $542.0K
Total Liabilities $20.64M
YoY Change -8.77%
SHAREHOLDERS EQUITY
Retained Earnings -$270.5M
YoY Change 0.51%
Common Stock $17.00K
YoY Change 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.6M
YoY Change
Total Liabilities & Shareholders Equity $138.2M
YoY Change -1.51%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $1.874M
YoY Change -142.46%
Depreciation, Depletion And Amortization $231.0K
YoY Change -23.0%
Cash From Operating Activities $6.205M
YoY Change -659.01%
INVESTING ACTIVITIES
Capital Expenditures $1.687M
YoY Change 16770.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.687M
YoY Change 5523.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -437.0K
YoY Change -218.11%
NET CHANGE
Cash From Operating Activities 6.205M
Cash From Investing Activities -1.687M
Cash From Financing Activities -437.0K
Net Change In Cash 4.081M
YoY Change -630.0%
FREE CASH FLOW
Cash From Operating Activities $6.205M
Capital Expenditures $1.687M
Free Cash Flow $4.518M
YoY Change -503.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001803901
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 talk Accrued Severance
AccruedSeverance
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39314
dei Entity Registrant Name
EntityRegistrantName
TALKSPACE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4636604
dei Entity Address Address Line1
EntityAddressAddressLine1
622 Third Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
284-7206
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
168922789
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118994000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123908000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9602000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10174000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2922000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5718000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
131518000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
139800000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6713000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2421000
CY2024Q3 us-gaap Assets
Assets
138231000
CY2023Q4 us-gaap Assets
Assets
142221000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8299000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6111000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3507000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3069000
CY2024Q3 talk Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
7247000
CY2023Q4 talk Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12468000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
19053000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21648000
CY2024Q3 talk Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
1048000
CY2023Q4 talk Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
1842000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
542000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
85000
CY2024Q3 us-gaap Liabilities
Liabilities
20643000
CY2023Q4 us-gaap Liabilities
Liabilities
23575000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168824458
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168824458
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168428856
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168428856
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
17000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
16000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
388021000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
389014000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270450000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270384000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
117588000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118646000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138231000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142221000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47399000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38646000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
138873000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107627000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
25778000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
19797000
us-gaap Cost Of Revenue
CostOfRevenue
74570000
us-gaap Cost Of Revenue
CostOfRevenue
54218000
CY2024Q3 us-gaap Gross Profit
GrossProfit
21621000
CY2023Q3 us-gaap Gross Profit
GrossProfit
18849000
us-gaap Gross Profit
GrossProfit
64303000
us-gaap Gross Profit
GrossProfit
53409000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2352000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4180000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8254000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13704000
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1677000
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1405000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4802000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4681000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12337000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13184000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38615000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
39698000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5156000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5259000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17698000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15952000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
21522000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
24028000
us-gaap Operating Expenses
OperatingExpenses
69369000
us-gaap Operating Expenses
OperatingExpenses
74035000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
99000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5179000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5066000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20626000
CY2024Q3 talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-1701000
CY2023Q3 talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-779000
talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-5123000
talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-2915000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1800000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
57000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17711000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-74000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
123000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
165000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1874000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4414000
us-gaap Net Income Loss
NetIncomeLoss
-66000
us-gaap Net Income Loss
NetIncomeLoss
-17876000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168426349
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166570673
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168805882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164215802
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173753763
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166570673
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168805882
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164215802
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118646000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
741000
CY2024Q1 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-595000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2252000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1466000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
119578000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
843000
CY2024Q2 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-1248000
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
8004000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3349000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-474000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
114044000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
32000
CY2024Q3 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-468000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2106000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1874000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
117588000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
127536000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
621000
CY2023Q1 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-65000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2303000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8758000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
121637000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
869000
CY2023Q2 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-136000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2129000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4704000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
119795000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
569000
CY2023Q3 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-198000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1969000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4414000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
117721000
us-gaap Net Income Loss
NetIncomeLoss
-66000
us-gaap Net Income Loss
NetIncomeLoss
-17876000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
652000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
913000
us-gaap Share Based Compensation
ShareBasedCompensation
7290000
us-gaap Share Based Compensation
ShareBasedCompensation
6401000
talk Remeasurement Of Warrant Liabilities
RemeasurementOfWarrantLiabilities
794000
talk Remeasurement Of Warrant Liabilities
RemeasurementOfWarrantLiabilities
-647000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-572000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1668000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2796000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
41000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2188000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-438000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
733000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5220000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5785000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-233000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-108000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7623000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14863000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
3768000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
69000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3837000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1616000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2059000
talk Payments For Employee Taxes Withheld Related To Restricted Stock Units Vested
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
2312000
talk Payments For Employee Taxes Withheld Related To Restricted Stock Units Vested
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
399000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8004000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8700000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1660000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4914000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13213000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123908000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138545000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118994000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125332000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
199000
talk Non Cash Investing Lease Liabilities Arising From Obtaining Right Of Use Assets
NonCashInvestingLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
595000
talk Non Cash Investing Lease Liabilities Arising From Obtaining Right Of Use Assets
NonCashInvestingLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
0
talk Non Cash Compensation Capitalized As Part Of Capitalization Of Internal Use Software Costs
NonCashCompensationCapitalizedAsPartOfCapitalizationOfInternalUseSoftwareCosts
417000
talk Non Cash Compensation Capitalized As Part Of Capitalization Of Internal Use Software Costs
NonCashCompensationCapitalizedAsPartOfCapitalizationOfInternalUseSoftwareCosts
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the condensed consolidated financial statements. The Company’s significant estimates and assumptions used in these condensed consolidated financial statements include, but are not limited to, the recognition of revenue, stock-based compensation awards and internal-use software costs. The Company bases its estimates on historical factors, current circumstances and the experience and judgment of management. The Company evaluates its assumptions on an ongoing basis. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based on information available at the time they are made. Estimates, by their nature, are based on judgment and available information, therefore, actual results could be materially different from these estimates.</span></p>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47399000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38646000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
138873000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107627000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5423000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1202000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1094000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
888000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4329000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
314000
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200000
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
200000
us-gaap Legal Fees
LegalFees
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1931000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1969000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7290000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6401000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1874000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4414000
us-gaap Net Income Loss
NetIncomeLoss
-66000
us-gaap Net Income Loss
NetIncomeLoss
-17876000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168426349
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166570673
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168805882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164215802
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5327414
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173753763
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166570673
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168805882
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164215802
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q3 talk Accrued Employee Compensation
AccruedEmployeeCompensation
4018000
CY2023Q4 talk Accrued Employee Compensation
AccruedEmployeeCompensation
7269000
CY2024Q3 talk Accrued Severance
AccruedSeverance
726000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
874000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
626000
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
664000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1525000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
965000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3048000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7247000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12468000
CY2025Q4 ecd Trd Arr Expiration Date
TrdArrExpirationDate
December 31, 2025

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-123526-index-headers.html Edgar Link pending
0000950170-24-123526-index.html Edgar Link pending
0000950170-24-123526.txt Edgar Link pending
0000950170-24-123526-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
talk-20240930.htm Edgar Link pending
talk-20240930.xsd Edgar Link pending
talk-ex31_1.htm Edgar Link pending
talk-ex31_2.htm Edgar Link pending
talk-ex32_1.htm Edgar Link pending
talk-ex32_2.htm Edgar Link pending
talk-20240930_htm.xml Edgar Link completed